Securities Fraud
搜索文档
PHH, BYAH DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH
TMX Newsfile· 2026-09-22 00:29
New York, New York--(Newsfile Corp. - September 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or cost ...
CLASS ACTION REMINDER: Berger Montague Advises Datavault AI Inc. (DVLT) Investors to Inquire About a Securities Fraud Lawsuit by October 5, 2026
TMX Newsfile· 2026-09-22 00:06
Philadelphia, Pennsylvania--(Newsfile Corp. - September 21, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT) ("Datavault" or the "Company") on behalf of investors who purchased or acquired Datavault securities during the period from September 4, 2024 through October 30, 2025 (the "Class Period").Investor Deadline: Investors who purchased or acquired Datavault securities during the Class Period may, no later than October 5, 20 ...
HIMS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
TMX Newsfile· 2026-09-21 23:47
公司核心事件 - 美国证券律师事务所Faruqi & Faruqi正在调查Hims & Hers Health公司潜在索赔,并提醒投资者2026年11月2日为寻求首席原告角色的截止日期[2] - 联邦证券集体诉讼已针对该公司提起[2] - 2026年7月29日盘中,联邦贸易委员会宣布对Hims提起诉讼,指控其将消费者敏感健康信息与第三方广告平台共享,并在计费和取消做法上欺骗用户[6] - 该消息导致Hims股价下跌4.32美元,跌幅14.73%,收于每股25.00美元,交易量异常巨大[6] 诉讼指控内容 - 公司及其高管违反联邦证券法,作出虚假和/或误导性陈述,未披露以下事实[5] - 公司与第三方广告平台共享消费者健康信息[5][9] - 公司在消费者提交摄入表后几乎立即收取处方费用,尽管告知消费者将能咨询医疗提供者以找到“适合他们”的治疗方案[5][9] - 上述行为使公司面临监管审查[5][9] - 因此公司合理可能产生费用和罚款[5][9] - 被告关于公司业务、运营和前景的积极陈述具有重大误导性和/或缺乏合理依据[5][9] 集体诉讼参与资格 - 在2025年8月4日至2026年7月29日期间(含首尾日)购买或收购Hims & Hers Health公司证券的投资者可能有资格参与集体诉讼[1][10] - 任何在集体诉讼期间购买Hims证券的投资者均可成为集体成员,无需寻求首席原告任命[10] - 投资者可联系Faruqi & Faruqi合伙人Josh Wilson讨论法律权利,电话877-247-4292或212-983-9330(分机1310)[1] 首席原告角色 - 首席原告是法院指定的代表,代表所有集体成员指导诉讼,包括与律师合作制定案件策略和和解决定[11] - 任何在集体诉讼期间购买Hims证券并遭受损失的投资者可在2026年11月2日前向法院申请担任首席原告[11] - 法院通常指定在诉讼中拥有最大经济利益且满足联邦民事诉讼规则第23条要求的投资者或投资者团体担任首席原告[11] - 投资者无需寻求首席原告任命即可参与诉讼或分享任何潜在赔偿[11]